GERRESHEIMER AG, a well-known company in the pharmaceutical and healthcare sectors, is receiving positive attention from UBS analysts.

The company operates in two main segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment specializes in producing standard and customized drug delivery products, such as insulin pens, inhalers, and prefillable syringes. The Primary Packaging Glass segment is dedicated to manufacturing glass packaging solutions for pharmaceuticals, cosmetics, and the food and beverage industry.

Gerresheimer AG has around 40 production facilities strategically located across Europe, North America, South America, and Asia, which allows them to meet the growing demands of the global market.